Reject efforts to undermine America ’s R & D ecosystem

America ’s biopharmaceutical research companies are central to the research and development (R&D) of innovative medicines in the United States. Unfortunately, a new report by Sen. Sanders mischaracterizes the role the National Institutes of Health plays in the research and development (R&D) process and risks stifling the innovative biopharmaceutical ecosystem vital to advancing medicines for patients.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Intellectual Property Source Type: news